IP Verse

Immediate Release Tablet Formulations

Patent No. EP2498759 (titled "Immediate Release Tablet Formulations") was filed by Astrazeneca on Nov 12, 2010. The application was issued on Aug 1, 2018.

Patent Summary

Immediate release pharmaceutical formulation comprising metformin hydrochloride and a sodium-dependent glucose transporter inhibitor (SGLT2) selected from dapagliflozin and dapagliflozin (S) propylene glycol hydrate, for oral administration in the treatment of type 2 diabetes and related disorders. The formulation is prepared by spray granulation of the SGLT2 inhibitor onto metformin particles in a fluid bed, resulting in uniform content and improved compaction properties. The formulation includes hydroxypropyl cellulose as a binder, microcrystalline cellulose as a filler, sodium starch glycolate or hydroxypropyl cellulose as a disintegrant, and magnesium stearate as a lubricant.

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALENICUM HEALTH SLUMay 2, 2019GALENICUM HEALTH SLU
GENERICS UKApr 30, 2019TER MEER STEINMEISTER & PARTNER
HOEFER & PARTNER PATENTANWALTE MBBApr 30, 2019-
STADA ARZNEIMITTELApr 30, 2019KERNEBECK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2498759

ASTRAZENECA
Application Number
EP10782116A
Filing Date
Nov 12, 2010
Status
Granted And Under Opposition
Jun 29, 2018
Publication Date
Aug 1, 2018
External Links
Slate, Register , Google Patents